Peter Kirkbride

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

David P. Dearnaley, Isabel Syndikus, Helen Mossop et al. · The Lancet Oncology · 2016 · 1.3K citations · Full text

Medicine, Oncology, Radiation Oncology +17

Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines

Richard J. Gralla, David Osoba, Mark G. Kris et al. · Journal of Clinical Oncology · 1999 · 670 citations

Medicine, Oncology, Pharmacotherapy +15

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

Padraig Warde, Malcolm Mason, Keyue Ding et al. · The Lancet · 2011 · 580 citations

Medicine, Oncology, Urology +16

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial

David P. Dearnaley, Isabel Syndikus, G. Sumo et al. · The Lancet Oncology · 2011 · 308 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer

Malcolm D. Mason, Wendy R. Parulekar, Matthew R. Sydes et al. · Journal of Clinical Oncology · 2015 · 259 citations · Full text

Medicine, Oncology, Radiation Oncology +14